Skip to main content
. 2023 Jun 8;13:103. doi: 10.1186/s13578-023-01061-z

Fig. 2.

Fig. 2

A: Venn diagram showing the intersection of differential genes with consistent expression trends in residual tumor cells after neoadjuvant chemotherapy for LUAD, ESCC, and cisplatin-resistant cell lines; B: Expression of 12 genes in tumor cells before and after neoadjuvant therapy for lung adenocarcinoma; C: Expression of 12 genes in tumor cells before and after neoadjuvant therapy for ECC